These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
600 related articles for article (PubMed ID: 30217627)
1. Rotational Atherectomy Combined with Drug Coated-Balloons for in-Stent Restenosis. Allan M; Vickers D; Pitney M; Jepson N Cardiovasc Revasc Med; 2019 Jul; 20(7):559-562. PubMed ID: 30217627 [TBL] [Abstract][Full Text] [Related]
2. High-Speed Rotational Atherectomy Versus Modified Balloons Prior to Drug-Eluting Stent Implantation in Severely Calcified Coronary Lesions. Abdel-Wahab M; Toelg R; Byrne RA; Geist V; El-Mawardy M; Allali A; Rheude T; Robinson DR; Abdelghani M; Sulimov DS; Kastrati A; Richardt G Circ Cardiovasc Interv; 2018 Oct; 11(10):e007415. PubMed ID: 30354632 [TBL] [Abstract][Full Text] [Related]
3. 3-Year Clinical Follow-Up of the RIBS IV Clinical Trial: A Prospective Randomized Study of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis in Coronary Arteries Previously Treated With Drug-Eluting Stents. Alfonso F; Pérez-Vizcayno MJ; Cuesta J; García Del Blanco B; García-Touchard A; López-Mínguez JR; Masotti M; Zueco J; Cequier A; Velázquez M; Moreno R; Mainar V; Domínguez A; Moris C; Molina E; Rivero F; Jiménez-Quevedo P; Gonzalo N; Fernández-Pérez C; JACC Cardiovasc Interv; 2018 May; 11(10):981-991. PubMed ID: 29798776 [TBL] [Abstract][Full Text] [Related]
4. Impact of Optimized Procedure-Related Factors in Drug-Eluting Balloon Angioplasty for Treatment of In-Stent Restenosis. Rhee TM; Lee JM; Shin ES; Hwang D; Park J; Jeon KH; Kim HL; Yang HM; Han JK; Park KW; Hahn JY; Koo BK; Kim SH; Kim HS JACC Cardiovasc Interv; 2018 May; 11(10):969-978. PubMed ID: 29798774 [TBL] [Abstract][Full Text] [Related]
5. Two-year results and subgroup analyses of the PEPCAD China in-stent restenosis trial: A prospective, multicenter, randomized trial for the treatment of drug-eluting stent in-stent restenosis. Xu B; Qian J; Ge J; Wang J; Chen F; Chen J; Wei M; Chen Y; Yang Y; Gao R; Catheter Cardiovasc Interv; 2016 Mar; 87 Suppl 1():624-9. PubMed ID: 26775079 [TBL] [Abstract][Full Text] [Related]
6. Angiographic patterns of drug-eluting stent restenosis after treatment with drug-coated balloon versus balloon angioplasty: Late lumen loss subgroup analyses of the PEPCAD-DES study. Rittger H; Wöhrle J; Brachmann J; Hohenforst-Schmidt W; Schlundt C; Lonke S; von Cranach M; Markovic S; Achenbach S; Waliszewski M Catheter Cardiovasc Interv; 2016 Oct; 88(4):529-534. PubMed ID: 26893095 [TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of rotational atherectomy for the treatment of undilatable underexpanded stents implanted in calcific lesions. Ferri LA; Jabbour RJ; Giannini F; Benincasa S; Ancona M; Regazzoli D; Mangieri A; Montorfano M; Colombo A; Latib A Catheter Cardiovasc Interv; 2017 Aug; 90(2):E19-E24. PubMed ID: 27862848 [TBL] [Abstract][Full Text] [Related]
8. Treatment of Coronary Drug-Eluting Stent Restenosis by a Sirolimus- or Paclitaxel-Coated Balloon. Ali RM; Abdul Kader MASK; Wan Ahmad WA; Ong TK; Liew HB; Omar AF; Mahmood Zuhdi AS; Nuruddin AA; Schnorr B; Scheller B JACC Cardiovasc Interv; 2019 Mar; 12(6):558-566. PubMed ID: 30898253 [TBL] [Abstract][Full Text] [Related]
9. Comparison between drug-coated balloon angioplasty and second-generation drug-eluting stent placement for the treatment of in-stent restenosis after drug-eluting stent implantation. Kang IS; Shehata I; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK Heart Vessels; 2016 Sep; 31(9):1405-11. PubMed ID: 26337620 [TBL] [Abstract][Full Text] [Related]
10. Neointimal Modification With Scoring Balloon and Efficacy of Drug-Coated Balloon Therapy in Patients With Restenosis in Drug-Eluting Coronary Stents: A Randomized Controlled Trial. Kufner S; Joner M; Schneider S; Tölg R; Zrenner B; Repp J; Starkmann A; Xhepa E; Ibrahim T; Cassese S; Fusaro M; Ott I; Hengstenberg C; Schunkert H; Abdel-Wahab M; Laugwitz KL; Kastrati A; Byrne RA; JACC Cardiovasc Interv; 2017 Jul; 10(13):1332-1340. PubMed ID: 28683939 [TBL] [Abstract][Full Text] [Related]
11. A novel drug-coated scoring balloon for the treatment of coronary in-stent restenosis: Results from the multi-center randomized controlled PATENT-C first in human trial. Scheller B; Fontaine T; Mangner N; Hoffmann S; Bonaventura K; Clever YP; Chamie D; Costa R; Gershony G; Kelsch B; Kutschera M; Généreux P; Cremers B; Böhm M; Speck U; Abizaid A Catheter Cardiovasc Interv; 2016 Jul; 88(1):51-9. PubMed ID: 26331782 [TBL] [Abstract][Full Text] [Related]
12. Long-Term Efficacy and Safety of Paclitaxel-Eluting Balloon for the Treatment of Drug-Eluting Stent Restenosis: 3-Year Results of a Randomized Controlled Trial. Kufner S; Cassese S; Valeskini M; Neumann FJ; Schulz-Schüpke S; Hoppmann P; Fusaro M; Schunkert H; Laugwitz KL; Kastrati A; Byrne RA; JACC Cardiovasc Interv; 2015 Jun; 8(7):877-84. PubMed ID: 26003022 [TBL] [Abstract][Full Text] [Related]
13. Second-generation drug-eluting stents versus drug-coated balloons for the treatment of coronary in-stent restenosis: A systematic review and meta-analysis. Kokkinidis DG; Prouse AF; Avner SJ; Lee JM; Waldo SW; Armstrong EJ Catheter Cardiovasc Interv; 2018 Aug; 92(2):285-299. PubMed ID: 29024274 [TBL] [Abstract][Full Text] [Related]
14. Comparison of 2 Different Drug-Coated Balloons in In-Stent Restenosis: The RESTORE ISR China Randomized Trial. Chen Y; Gao L; Qin Q; Chen S; Zhang J; Chen H; Wang L; Jin Z; Zheng Y; Zhang Z; Li H; Li X; Fu G; Chen L; Sun Z; Wang Y; Jin Q; Cao F; Guo J; Zhao Y; Guan C; Li W; Xu B; JACC Cardiovasc Interv; 2018 Dec; 11(23):2368-2377. PubMed ID: 30522665 [TBL] [Abstract][Full Text] [Related]
15. Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis: the three-year results of the PEPCAD II ISR study. Unverdorben M; Vallbracht C; Cremers B; Heuer H; Hengstenberg C; Maikowski C; Werner GS; Antoni D; Kleber FX; Bocksch W; Leschke M; Ackermann H; Boxberger M; Speck U; Degenhardt R; Scheller B EuroIntervention; 2015 Dec; 11(8):926-34. PubMed ID: 25169589 [TBL] [Abstract][Full Text] [Related]
16. The SABRE Trial (Sirolimus Angioplasty Balloon for Coronary In-Stent Restenosis): Angiographic Results and 1-Year Clinical Outcomes. Verheye S; Vrolix M; Kumsars I; Erglis A; Sondore D; Agostoni P; Cornelis K; Janssens L; Maeng M; Slagboom T; Amoroso G; Jensen LO; Granada JF; Stella P JACC Cardiovasc Interv; 2017 Oct; 10(20):2029-2037. PubMed ID: 28964764 [TBL] [Abstract][Full Text] [Related]
17. Long-term clinical safety and efficacy of drug-coated balloon in the treatment of in-stent restenosis: A meta-analysis and systematic review. Xi Y; Chen J; Bi Y; Xie S; Liao T; Zhang Y; Kislauskis E; Wu T; Laham R; Xiao J Catheter Cardiovasc Interv; 2020 Aug; 96(2):E129-E141. PubMed ID: 31714010 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of Drug-Eluting Balloons for Patients With In-Stent Restenosis: A Meta-Analysis of 8 Randomized Controlled Trials. Gao S; Shen J; Mukku VK; Wang MJ; Akhtar M; Liu W Angiology; 2016 Aug; 67(7):612-21. PubMed ID: 26483569 [TBL] [Abstract][Full Text] [Related]
19. A comparison between drug-eluting stent implantation and drug-coated balloon angioplasty in patients with left main bifurcation in-stent restenotic lesions. Kook H; Joo HJ; Park JH; Hong SJ; Yu CW; Lim DS BMC Cardiovasc Disord; 2020 Feb; 20(1):83. PubMed ID: 32070287 [TBL] [Abstract][Full Text] [Related]
20. Clinical Outcomes of Drug-Eluting Balloon for In-Stent Restenosis Based on the Number of Metallic Layers. Yabushita H; Kawamoto H; Fujino Y; Tahara S; Horikoshi T; Tada M; Amano T; Onishi H; Nakajima A; Warisawa T; Watanabe Y; Yoshizaki T; Mitomo S; Sato T; Naganuma T; Ishiguro H; Kurita N; Nakamura S; Hozawa K; Nakamura S Circ Cardiovasc Interv; 2018 Aug; 11(8):e005935. PubMed ID: 30354780 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]